| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |